跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMVEXXY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IMVEXXY
Authorized
STANDARD
IMVEXXY
knight therapeutics inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
254206e9ec27b9da
Company
knight therapeutics inc.
Type
Standard
Approval Details
Approval Id
254206e9ec27b9da
Drug Approval Canada Name
IMVEXXY
Product Name
IMVEXXY
Status
Marketed
Status Date
2023-11-14
Original Market Date
2023-11-14
Din
02503689
Drug Class
Human
Dosage Form
Insert
Route Of Administration
Vaginal
Schedule
Prescription
Ahfs
68:16.04
Atc Original
G03CA03 ESTRADIOL
Atc Name
g 03 ca 03
Aig Number
0106457038
Company Name
knight therapeutics inc.
Company Address
1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8
Active Ingredients
ESTRADIOL (ESTRADIOL HEMIHYDRATE)
4 MCG / INSERT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
254206e9ec27b9da
Type
Standard
Back to Health Canada Approvals